Ledger.Open graph →
SEC Form D · filed November 8, 2019

InCarda Therapeutics, Inc

Offering
$42.1M
Sold
$35.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEWARK, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Grace Colon · NEWARK, CAExec · DirectorDan Welch · NEWARK, CADirectorAlan Colowick · NEWARK, CADirectorJohan Christenson · NEWARK, CADirectorAndrew Elbardissi · NEWARK, CADirectorIsaac Cheng · Charlestown, MADirectorArun Kurichety · Irvine, CADirectorBoris Said · Carlsbad, CAExec · DirectorMark Simo · Carlsbad, CADirectorJonathan Ghitis · Aventura, FLDirectorBrian Simo · Carlsbad, CADirectorBischofberger Norbert · Brisbane, CADirectorEarl Jones · Cambridge, MAExec · DirectorRichard Brenner · ORLANDO, FLDirectorMichael Otworth · ORLANDO, FLDirectorJames Donnally · ORLANDO, FLDirectorGreg Wasson · ORLANDO, FLDirectorIsaac Cheng · Cambridge, MADirectorBischofberger Norbert · Brisbane, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗